Free Trial

Kubient (KBNT) Competitors

Kubient logo

KBNT vs. KLDO, ALFIW, APCXW, ARBEW, AOGOW, AOGOU, AUROW, AVPTW, BNIXW, and BNIXR

Should you be buying Kubient stock or one of its competitors? The main competitors of Kubient include Kaleido Biosciences (KLDO), Alfi (ALFIW), AppTech Payments (APCXW), Arbe Robotics (ARBEW), Arogo Capital Acquisition (AOGOW), Arogo Capital Acquisition (AOGOU), Aurora Innovation (AUROW), AvePoint (AVPTW), Bannix Acquisition (BNIXW), and Bannix Acquisition (BNIXR). These companies are all part of the "computer software" industry.

Kubient vs. Its Competitors

Kaleido Biosciences (NASDAQ:KLDO) and Kubient (NASDAQ:KBNT) are both small-cap computer software companies, but which is the better business? We will compare the two companies based on the strength of their risk, institutional ownership, valuation, media sentiment, dividends, analyst recommendations, profitability and earnings.

81.6% of Kaleido Biosciences shares are held by institutional investors. Comparatively, 13.9% of Kubient shares are held by institutional investors. 9.0% of Kaleido Biosciences shares are held by insiders. Comparatively, 22.3% of Kubient shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Kaleido Biosciences has a beta of -0.06, meaning that its stock price is 106% less volatile than the S&P 500. Comparatively, Kubient has a beta of 1.04, meaning that its stock price is 4% more volatile than the S&P 500.

In the previous week, Kaleido Biosciences' average media sentiment score of 0.00 equaled Kubient'saverage media sentiment score.

Company Overall Sentiment
Kaleido Biosciences Neutral
Kubient Neutral

Kubient has higher revenue and earnings than Kaleido Biosciences.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Kaleido Biosciences$1.10M0.00-$95.48M-$2.24N/A
Kubient$1.17M0.00-$13.62MN/AN/A

Company Net Margins Return on Equity Return on Assets
Kaleido BiosciencesN/A N/A N/A
Kubient N/A N/A N/A

Summary

Kubient beats Kaleido Biosciences on 4 of the 5 factors compared between the two stocks.

Get Kubient News Delivered to You Automatically

Sign up to receive the latest news and ratings for KBNT and its competitors with MarketBeat's FREE daily newsletter.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

KBNT vs. The Competition

MetricKubientComputer integrated systems design IndustryBusiness SectorNASDAQ Exchange
Market Cap$1K$1.22B$13.09B$9.02B
Dividend YieldN/A2.62%2.54%3.99%
P/E RatioN/A2.2228.8920.25
Price / SalesN/A0.3640.66119.26
Price / CashN/A9.4426.1328.59
Price / BookN/A3.466.295.65
Net Income-$13.62M$223.79M$188.88M$249.15M

Kubient Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
KBNT
Kubient
N/AN/AN/AN/A$1K$1.17M0.0040
KLDO
Kaleido Biosciences
N/A$0.00
flat
N/AN/A$4K$1.10M0.0080
ALFIW
Alfi
N/AN/AN/AN/A$0.00$200.68K0.0040
APCXW
AppTech Payments
N/A$0.08
flat
N/AN/A$0.00$276K0.0020
ARBEW
Arbe Robotics
N/A$0.24
-21.3%
N/A-0.6%$0.00$671K0.00120Positive News
AOGOW
Arogo Capital Acquisition
N/A$0.03
flat
N/AN/A$0.00N/A0.00N/A
AOGOU
Arogo Capital Acquisition
N/A$8.50
flat
N/AN/A$0.00N/A0.00N/A
AUROW
Aurora Innovation
N/A$0.82
-5.7%
N/A+272.7%$0.00$2M0.001,700Gap Down
AVPTW
AvePoint
N/A$7.05
-9.3%
N/A+361.0%$0.00$349.01M0.001,930Positive News
BNIXW
Bannix Acquisition
N/A$0.06
+27.3%
N/AN/A$0.00N/A0.003Gap Down
BNIXR
Bannix Acquisition
N/A$0.24
+0.8%
N/AN/A$0.00N/A0.003Gap Down

Related Companies and Tools


This page (NASDAQ:KBNT) was last updated on 7/7/2025 by MarketBeat.com Staff
From Our Partners